
A systematic review highlights that AI model architecture, more than data or imaging specifics, drives improved tumor segmentation in brain MRI scans.
Key Details
- 1Researchers from the University of Auckland and affiliated institutes reviewed 34 studies on AI-based meningioma segmentation using MRI (2020-2025).
- 2Advanced AI architectures, such as DeepLabV3+, achieved the highest Dice scores (up to 0.98), indicating superior delineation performance.
- 3Model performance tiers were identified: Tier 1 (Dice 0.9-1, hybrid/advanced models), Tier 2 (Dice 0.8-0.9, e.g. 2D U-Net), Tier 3 (Dice <0.82, lightweight models).
- 4Data and imaging modality improvements contributed less to performance than advancements in AI architectures.
- 5Challenges remain, including underperformance for small tumors (<3 mL), high computational demands, and limited generalizability across hospitals.
- 6Most studies used contrast-enhanced T1 MRI; real-world deployment still faces workflow and infrastructure hurdles.
Why It Matters

Source
EurekAlert
Related News

UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.

Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.

Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.